Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 10/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8132698 | 0.88 | MAPK1 (0.36) | PTGESMAPK1KDM4EALDH1A1NPSR1 | |
| SCHEMBL7325188 | 0.86 | KDM4E (0.34) | PTGESMAPK1KDM4EALDH1A1NPSR1 | |
| SCHEMBL6600592 | 0.78 | HTR4 (0.38) | MAPK1KDM4EALDH1A1SMN1; SMN2GAA | |
| SCHEMBL4242110 | 0.77 | NPSR1 (0.39) | PTGESMAPK1ALDH1A1ALOX5NPSR1 | |
| SCHEMBL8131719 | 0.76 | SMN1; SMN2 (0.40) | KDM4EALDH1A1NPSR1PKMSMN1; SMN2 | |
| SCHEMBL8690082 | 0.76 | KDM4E (0.37) | MAPK1KDM4EALDH1A1SMN1; SMN2GAA | |
| SCHEMBL506259 | 0.76 | ALDH1A1 (0.40) | MAPK1KDM4EALDH1A1NPSR1SMN1; SMN2 | |
| SCHEMBL2698798 | 0.75 | KDM4E (0.40) | KDM4EALDH1A1GAAMAPTHPGD | |
| SCHEMBL7325147 | 0.75 | ALDH1A1 (0.36) | MAPK1KDM4EALDH1A1SMN1; SMN2GAA | |
| SCHEMBL2699346 | 0.73 | ALDH1A1 (0.41) | KDM4EALDH1A1GAATP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5739134-A | TREATMENT OF GASTROINTESTINAL DISORDERS, DECREASED PERISTALSIS | JANSSEN PHARMACETUICA N.V. (BE) | 1998-04-14 | — | — | US | disclosed |
| US-5616738-A | A 7-CARBOXYBENZOFURAN INTERMEDIATE FOR DRUGS HAVING GASTROINTESTINAL MOTILITY STIMULATING PROPERTIES | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-04-01 | — | — | US | disclosed |
| US-5616583-A | GASTROINTESTINAL MOTILITY | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-04-01 | — | — | US | disclosed |
| US-5610157-A | N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzo-dioxin) carboxamide derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-03-11 | — | — | US | disclosed |
| US-5602129-A | GASTROINTESTINAL DISORDERS | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-02-11 | — | — | US | disclosed |
| US-5576448-A | GASTROINTESTINAL DISORDERS, ANTIEMETICS, ANTIPSYCHOTICS OR NEUROLEPTIC AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-11-19 | — | — | US | disclosed |
| US-5554772-A | CHEMICAL INTERMEDIATES; GASTROINTESTINAL DISORDERS | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-09-10 | — | — | US | disclosed |
| US-5552553-A | CHEMICAL INTERMEDIATES FOR LAXATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-09-03 | — | — | US | disclosed |
| US-5536733-A | GASTROINTESTINAL | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-07-16 | — | — | US | disclosed |
| US-5521314-A | CHEMICAL INTERMEDIATES FOR CENTRAL NERVOUS SYSTEM, ANTIEMETICS, ANTIPSYCHOTIC AGENTS OR NEUROLEPTIC AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-05-28 | — | — | US | disclosed |
| EP-0389037-B1 | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives | JANSSEN PHARMACEUTICA NV (BE) | 1995-09-20 | — | — | EP | disclosed |
| US-5374637-A | Stimulate gastrointestinal motility | JANSSEN PHARMACEUTICA N.V. (BE) | 1994-12-20 | — | — | US | disclosed |
| EP-0389037-A1 | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-09-26 | — | — | EP | disclosed |